Results 51 to 60 of about 41,151 (199)

Mitigating gut microbial degradation of levodopa and enhancing brain dopamine: Implications in Parkinson’s disease

open access: yesCommunications Biology
Parkinson’s disease is managed using levodopa; however, as Parkinson’s disease progresses, patients require increased doses of levodopa, which can cause undesirable side effects. Additionally, the oral bioavailability of levodopa decreases in Parkinson’s
Gang Cheng   +4 more
doaj   +1 more source

Highly efficient electrocatalytic oxidation of levodopa as a Parkinson therapeutic drug based on modified screen-printed electrode

open access: yesHeliyon
The current study presents the creation of a straightforward and sensitive sensor based on ZnO/Co3O4 nanocomposite modified screen-printed electrode (ZnO/Co3O4NC/SPE) for levodopa determination. At ZnO/Co3O4NC/SPE, an oxidative peak for levodopa solution
Tan Wang   +10 more
doaj   +1 more source

Action of Thymoxamine on Mydriasis induced by Levodopa and Dopamine [PDF]

open access: bronze, 1971
A. S. D. Spiers   +3 more
openalex   +1 more source

Patient Selection in Deep Brain Stimulation: A Role for Transcranial Direct Current Stimulation to Enhance the Levodopa Challenge?

open access: yesAnnals of Clinical and Translational Neurology
Dopaminergic medication and deep brain stimulation (DBS) improve motor symptoms in Parkinson's disease (PD), but levodopa response alone may not predict DBS outcomes.
Lukas L. Goede   +3 more
doaj   +1 more source

Letter: Levodopa in coma due to fulminant hepatitis. [PDF]

open access: bronze, 1975
P A Contoyiannis   +3 more
openalex   +1 more source

Levodopa versus levodopa sparing in early parkinson’s disease: can we meet halfway?

open access: yesRevista de Investigación Clínica
Monotherapy is the recommended initial treatment for early Parkinson’s disease. The pharmacological options for initial treatment include dopaminergic agonists, monoamine oxidase B inhibitors, and levodopa formulations.
Mayela Rodríguez-Violante   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy